Patrick Harrison Carroll - 28 Feb 2022 Form 4 Insider Report for Hims & Hers Health, Inc. (HIMS)

Role
Director
Signature
/s/ Soleil Boughton, Attorney-in-Fact
Issuer symbol
HIMS
Transactions as of
28 Feb 2022
Net transactions value
-$17,772
Form type
4
Filing time
02 Mar 2022, 15:46:24 UTC
Previous filing
28 Feb 2022
Next filing
11 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HIMS Class A Common Stock Options Exercise $76,794 +43,882 +210% $1.75* 64,739 28 Feb 2022 Direct
transaction HIMS Class A Common Stock Options Exercise $100,065 +41,179 +64% $2.43 105,918 28 Feb 2022 Direct
transaction HIMS Class A Common Stock Options Exercise $43,256 +17,801 +17% $2.43 123,719 28 Feb 2022 Direct
transaction HIMS Class A Common Stock Options Exercise $210,973 +86,820 +70% $2.43 210,539 28 Feb 2022 Direct
transaction HIMS Class A Common Stock Sale $448,859 -86,820 -41% $5.17 123,719 28 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HIMS Stock Option (right to buy) Options Exercise $0 -43,882 -100% $0.000000* 0 28 Feb 2022 Class A Common Stock 43,882 $1.75 Direct F2
transaction HIMS Stock Option (right to buy) Options Exercise $0 -41,179 -100% $0.000000* 0 28 Feb 2022 Class A Common Stock 41,179 $2.43 Direct F3
transaction HIMS Stock Option (right to buy) Options Exercise $0 -17,801 -100% $0.000000* 0 28 Feb 2022 Class A Common Stock 17,801 $2.43 Direct F3
transaction HIMS Stock Option (right to buy) Options Exercise $0 -86,820 -100% $0.000000* 0 28 Feb 2022 Class A Common Stock 86,820 $2.43 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $5.055 - $5.27. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F2 25% of the shares vested on the 12 month anniversary of the vesting commencement date of June 17, 2019, and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date.
F3 25% of the shares vested on the 12 month anniversary of the vesting commencement date of December 5, 2019, and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the 12 month anniversary of the vesting commencement date.
F4 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous service beginning February 12, 2020.